Invitrogen

BTD Polyclonal Antibody

BTD Antibody in Immunohistochemistry (Paraffin) (IHC (P))

图: 1 / 3

BTD Antibody (PA5-28180) in IHC (P)

BTD Polyclonal Antibody detects BTD protein at cytosol on mouse hind brain by immunohistochemical analysis. Sample: Paraffin-embedded mouse hind brain. BTD Polyclonal Antibody (Product # PA5-28180) dilution: 1:250. Antigen Retrieval: EDTA based buffer, pH 8.0, 15 min.

BTD Antibody in Immunohistochemistry (IHC)

Product Image Gallery

产品信息

PA5-28180

应用

建议稀释比

已发表文章

免疫印迹 (WB)

1:500-1:3,000

免疫组化 (IHC)

查看1篇已发表文章 1篇已发表文章

免疫组化（石蜡） (IHC (P))

1:100-1:1,000

产品规格

种属反应

Human, Mouse

已发表种属

Human

宿主/亚型

Rabbit / IgG

分类

Polyclonal

类型

Antibody

抗原

Recombinant fragment corresponding to a region within amino acids 206 and 489 of Human BTD

查看免疫原

偶联物

Unconjugated Unconjugated Unconjugated

形式

Liquid

浓度

1 mg/mL

纯化类型

Antigen affinity chromatography

保存液

PBS, pH 7, with 1% BSA, 20% glycerol

内含物

0.01% thimerosal

保存条件

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

运输条件

Wet ice

AB_2545656

产品详细信息

Recommended positive controls: 293T, A431, Jurkat, Raji.

Predicted reactivity: Mouse (85%), Rat (81%), Chimpanzee (99%).

Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.

靶标信息

Biotinidase functions to recycle biotin in the body by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. Biotinidase has also been shown to have biotinyl-transferase activity. Defects in the biotinidase gene cause multiple carboxylase deficiency.

⚠WARNING: This product can expose you to chemicals including mercury, which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

仅用于科研。不用于诊断过程。未经明确授权不得转售。

Product References

Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas.

The Journal of pathology

Amato E,Mafficini A,Hirabayashi K,Lawlor RT,Fassan M,Vicentini C,Barbi S,Delfino P,Sikora K,Rusev B,Simbolo M,Esposito I,Antonello D,Pea A,Sereni E,Ballotta M,Maggino L,Marchegiani G,Ohike N,Wood LD,Salvia R,Klöppel G,Zamboni G,Scarpa A,Corbo V

PA5-28180 was used in Immunohistochemistry to suggest that BAP1 and KDM6A function is a barrier to the development of metastasis in a subset of SPNs, which might open novel avenues for the treatment of this disease.